Novel motif:127: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:13, 9 September 2013
name: | motif127_TTTTTACCCTC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0031328 | positive regulation of cellular biosynthetic process | 3.362230e-17 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 1.031575e-16 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1.131333e-16 |
GO:0009891 | positive regulation of biosynthetic process | 1.728965e-16 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 7.324058e-15 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 9.193038e-15 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1.690440e-14 |
GO:0051254 | positive regulation of RNA metabolic process | 2.384020e-14 |
GO:0010628 | positive regulation of gene expression | 3.927527e-14 |
GO:0031325 | positive regulation of cellular metabolic process | 1.263649e-13 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 2.327174e-12 |
GO:0009893 | positive regulation of metabolic process | 5.133284e-12 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 9.269057e-12 |
GO:0010604 | positive regulation of macromolecule metabolic process | 3.021723e-11 |
GO:0060325 | face morphogenesis | 2.529057e-10 |
GO:0044334 | canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition | 6.801854e-10 |
GO:0010909 | positive regulation of heparan sulfate proteoglycan biosynthetic process | 6.801854e-10 |
GO:0060323 | head morphogenesis | 9.125118e-10 |
GO:0030178 | negative regulation of Wnt receptor signaling pathway | 1.898748e-9 |
GO:0033032 | regulation of myeloid cell apoptosis | 3.295367e-9 |
GO:0007417 | central nervous system development | 4.259458e-9 |
GO:0042762 | regulation of sulfur metabolic process | 6.307380e-9 |
GO:0051176 | positive regulation of sulfur metabolic process | 1.139101e-8 |
GO:0051100 | negative regulation of binding | 1.284724e-8 |
GO:0060324 | face development | 1.435781e-8 |
GO:0032330 | regulation of chondrocyte differentiation | 1.477406e-8 |
GO:0061035 | regulation of cartilage development | 1.554264e-8 |
GO:0060322 | head development | 1.919595e-8 |
GO:0007420 | brain development | 2.966380e-8 |
GO:0010171 | body morphogenesis | 3.301876e-8 |
GO:0032102 | negative regulation of response to external stimulus | 3.513340e-8 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 3.709208e-8 |
GO:0009888 | tissue development | 4.329715e-8 |
GO:0048557 | embryonic digestive tract morphogenesis | 7.205610e-8 |
GO:0070417 | cellular response to cold | 8.314958e-8 |
GO:0007626 | locomotory behavior | 8.495587e-8 |
GO:0043586 | tongue development | 1.072657e-7 |
GO:0035411 | catenin import into nucleus | 1.127858e-7 |
GO:0030538 | embryonic genitalia morphogenesis | 1.903986e-7 |
GO:0030522 | intracellular receptor mediated signaling pathway | 3.173178e-7 |
GO:2000027 | regulation of organ morphogenesis | 3.519016e-7 |
GO:0045165 | cell fate commitment | 4.507603e-7 |
GO:0048598 | embryonic morphogenesis | 4.971601e-7 |
GO:0032880 | regulation of protein localization | 5.285461e-7 |
GO:0043393 | regulation of protein binding | 5.405599e-7 |
GO:0050905 | neuromuscular process | 6.264278e-7 |
GO:0046545 | development of primary female sexual characteristics | 6.860816e-7 |
GO:0061198 | fungiform papilla formation | 7.166832e-7 |
GO:0032501 | multicellular organismal process | 7.279988e-7 |
GO:0032091 | negative regulation of protein binding | 7.993369e-7 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 8.322045e-7 |
GO:2000370 | positive regulation of clathrin-mediated endocytosis | 8.995691e-7 |
GO:0048839 | inner ear development | 9.771539e-7 |
GO:0023052 | signaling | 1.106372e-6 |
GO:0060122 | inner ear receptor stereocilium organization | 1.128103e-6 |
GO:0045885 | positive regulation of survival gene product expression | 1.227874e-6 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 1.233303e-6 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.384627e-6 |
GO:0050974 | detection of mechanical stimulus involved in sensory perception | 1.498928e-6 |
GO:0042489 | negative regulation of odontogenesis of dentine-containing tooth | 1.591360e-6 |
GO:0043570 | maintenance of DNA repeat elements | 1.637703e-6 |
GO:0048585 | negative regulation of response to stimulus | 1.854756e-6 |
GO:0061196 | fungiform papilla development | 1.858941e-6 |
GO:0033238 | regulation of cellular amine metabolic process | 1.914460e-6 |
GO:0071107 | response to parathyroid hormone stimulus | 1.957183e-6 |
GO:0060527 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis | 1.964962e-6 |
GO:0008544 | epidermis development | 1.965328e-6 |
GO:0046660 | female sex differentiation | 1.992545e-6 |
GO:0010092 | specification of organ identity | 2.130739e-6 |
GO:0060443 | mammary gland morphogenesis | 2.440409e-6 |
GO:0046827 | positive regulation of protein export from nucleus | 2.933180e-6 |
GO:0007154 | cell communication | 3.161298e-6 |
GO:0033025 | regulation of mast cell apoptosis | 3.660094e-6 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 3.832710e-6 |
GO:0050982 | detection of mechanical stimulus | 4.054228e-6 |
GO:0032494 | response to peptidoglycan | 4.128216e-6 |
GO:0048332 | mesoderm morphogenesis | 4.462913e-6 |
GO:0010556 | regulation of macromolecule biosynthetic process | 4.794700e-6 |
GO:0048546 | digestive tract morphogenesis | 5.117158e-6 |
GO:0060119 | inner ear receptor cell development | 5.171463e-6 |
GO:0031326 | regulation of cellular biosynthetic process | 5.451291e-6 |
GO:0043583 | ear development | 5.548252e-6 |
GO:0060688 | regulation of morphogenesis of a branching structure | 6.010226e-6 |
GO:0006868 | glutamine transport | 6.012914e-6 |
GO:0033033 | negative regulation of myeloid cell apoptosis | 6.263451e-6 |
GO:0032495 | response to muramyl dipeptide | 6.332074e-6 |
GO:0018344 | protein geranylgeranylation | 6.336809e-6 |
GO:0032844 | regulation of homeostatic process | 6.872848e-6 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 7.614075e-6 |
GO:0035921 | desmosome disassembly | 7.614075e-6 |
GO:0043066 | negative regulation of apoptosis | 8.047945e-6 |
GO:0071383 | cellular response to steroid hormone stimulus | 8.072420e-6 |
GO:0007442 | hindgut morphogenesis | 8.095328e-6 |
GO:0050954 | sensory perception of mechanical stimulus | 8.101895e-6 |
GO:0043069 | negative regulation of programmed cell death | 8.231422e-6 |
GO:0022602 | ovulation cycle process | 9.281332e-6 |
GO:0007042 | lysosomal lumen acidification | 9.719046e-6 |
GO:0051971 | positive regulation of transmission of nerve impulse | 1.002499e-5 |
GO:0034197 | triglyceride transport | 1.015246e-5 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.038093e-5 |
GO:0022898 | regulation of transmembrane transporter activity | 1.055860e-5 |
GO:0001704 | formation of primary germ layer | 1.067318e-5 |
GO:0051098 | regulation of binding | 1.067490e-5 |
GO:0048333 | mesodermal cell differentiation | 1.070933e-5 |
GO:0009889 | regulation of biosynthetic process | 1.198437e-5 |
GO:0030514 | negative regulation of BMP signaling pathway | 1.227778e-5 |
GO:0048699 | generation of neurons | 1.262865e-5 |
GO:0010829 | negative regulation of glucose transport | 1.304342e-5 |
GO:0023051 | regulation of signaling | 1.314594e-5 |
GO:0048645 | organ formation | 1.351449e-5 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.391435e-5 |
GO:0009966 | regulation of signal transduction | 1.423508e-5 |
GO:0046325 | negative regulation of glucose import | 1.516426e-5 |
GO:0015980 | energy derivation by oxidation of organic compounds | 1.552630e-5 |
GO:0010648 | negative regulation of cell communication | 1.636839e-5 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.668222e-5 |
GO:0045637 | regulation of myeloid cell differentiation | 1.671971e-5 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1.700477e-5 |
GO:0008585 | female gonad development | 1.724018e-5 |
GO:0022612 | gland morphogenesis | 1.762735e-5 |
GO:0030900 | forebrain development | 1.806520e-5 |
GO:0008088 | axon cargo transport | 1.863595e-5 |
GO:0023057 | negative regulation of signaling | 1.974325e-5 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.005035e-5 |
GO:0009409 | response to cold | 2.027002e-5 |
GO:0009755 | hormone-mediated signaling pathway | 2.032707e-5 |
GO:0006355 | regulation of transcription, DNA-dependent | 2.118049e-5 |
GO:0050885 | neuromuscular process controlling balance | 2.136747e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 2.172863e-5 |
GO:0048583 | regulation of response to stimulus | 2.254418e-5 |
GO:0043496 | regulation of protein homodimerization activity | 2.395293e-5 |
GO:0031646 | positive regulation of neurological system process | 2.404196e-5 |
GO:0048625 | myoblast cell fate commitment | 2.469138e-5 |
GO:0060341 | regulation of cellular localization | 2.487709e-5 |
GO:0010646 | regulation of cell communication | 2.535535e-5 |
GO:0045824 | negative regulation of innate immune response | 2.784593e-5 |
GO:0014739 | positive regulation of muscle hyperplasia | 2.791380e-5 |
GO:0048732 | gland development | 2.791841e-5 |
GO:0032412 | regulation of ion transmembrane transporter activity | 2.877661e-5 |
GO:0002051 | osteoblast fate commitment | 3.070894e-5 |
GO:0008090 | retrograde axon cargo transport | 3.118693e-5 |
GO:0051179 | localization | 3.246749e-5 |
GO:0030326 | embryonic limb morphogenesis | 3.391187e-5 |
GO:0046654 | tetrahydrofolate biosynthetic process | 3.528453e-5 |
GO:0009719 | response to endogenous stimulus | 3.648816e-5 |
GO:0070646 | protein modification by small protein removal | 3.831541e-5 |
GO:0010468 | regulation of gene expression | 3.921397e-5 |
GO:0007091 | mitotic metaphase/anaphase transition | 4.082480e-5 |
GO:0042698 | ovulation cycle | 4.221674e-5 |
GO:0042221 | response to chemical stimulus | 4.250338e-5 |
GO:0060173 | limb development | 4.258992e-5 |
GO:0051704 | multi-organism process | 4.283049e-5 |
GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.323910e-5 |
GO:0048511 | rhythmic process | 4.355467e-5 |
GO:0046209 | nitric oxide metabolic process | 4.356420e-5 |
GO:0007399 | nervous system development | 4.595289e-5 |
GO:0060117 | auditory receptor cell development | 4.814383e-5 |
GO:0060548 | negative regulation of cell death | 4.978784e-5 |
GO:0042832 | defense response to protozoan | 5.064683e-5 |
GO:0010565 | regulation of cellular ketone metabolic process | 5.149426e-5 |
GO:0048566 | embryonic digestive tract development | 5.326615e-5 |
GO:0001707 | mesoderm formation | 5.488456e-5 |
GO:0060789 | hair follicle placode formation | 5.854736e-5 |
GO:0045089 | positive regulation of innate immune response | 6.093281e-5 |
GO:0031000 | response to caffeine | 6.106242e-5 |
GO:0001562 | response to protozoan | 6.177365e-5 |
GO:0006554 | lysine catabolic process | 6.478261e-5 |
GO:0021861 | forebrain radial glial cell differentiation | 6.565050e-5 |
GO:0048518 | positive regulation of biological process | 6.724533e-5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.726937e-5 |
GO:0042033 | chemokine biosynthetic process | 6.750590e-5 |
GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process | 6.750590e-5 |
GO:2000256 | positive regulation of male germ cell proliferation | 6.750590e-5 |
GO:0042231 | interleukin-13 biosynthetic process | 6.750590e-5 |
GO:0009653 | anatomical structure morphogenesis | 7.312528e-5 |
GO:0016579 | protein deubiquitination | 7.345835e-5 |
GO:0045666 | positive regulation of neuron differentiation | 7.395735e-5 |
GO:0070668 | positive regulation of mast cell proliferation | 7.584173e-5 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 7.584173e-5 |
GO:0001928 | regulation of exocyst assembly | 7.628443e-5 |
GO:0060178 | regulation of exocyst localization | 7.628443e-5 |
GO:0016578 | histone deubiquitination | 7.632883e-5 |
GO:0043588 | skin development | 7.848702e-5 |
GO:0048806 | genitalia development | 7.867590e-5 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 8.171167e-5 |
GO:2000612 | regulation of thyroid-stimulating hormone secretion | 8.212459e-5 |
GO:0048619 | embryonic hindgut morphogenesis | 8.324888e-5 |
GO:0022008 | neurogenesis | 8.337962e-5 |
GO:0042472 | inner ear morphogenesis | 8.692959e-5 |
GO:0071495 | cellular response to endogenous stimulus | 8.771045e-5 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 8.778340e-5 |
GO:0071168 | protein localization to chromatin | 9.324428e-5 |
GO:0070201 | regulation of establishment of protein localization | 9.524997e-5 |
GO:0007165 | signal transduction | 9.559792e-5 |
GO:0061039 | ovum-producing ovary development | 9.981038e-5 |
GO:0001780 | neutrophil homeostasis | 1.001760e-4 |
GO:2000036 | regulation of stem cell maintenance | 1.023187e-4 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.034168e-4 |
GO:2000736 | regulation of stem cell differentiation | 1.043381e-4 |
GO:0051239 | regulation of multicellular organismal process | 1.045406e-4 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.056589e-4 |
GO:0046883 | regulation of hormone secretion | 1.056997e-4 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 1.072789e-4 |
GO:0051726 | regulation of cell cycle | 1.084961e-4 |
GO:0051223 | regulation of protein transport | 1.086051e-4 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 1.097277e-4 |
GO:0032722 | positive regulation of chemokine production | 1.124749e-4 |
GO:0035129 | post-embryonic hindlimb morphogenesis | 1.128978e-4 |
GO:0035108 | limb morphogenesis | 1.152521e-4 |
GO:0002251 | organ or tissue specific immune response | 1.156201e-4 |
GO:0071363 | cellular response to growth factor stimulus | 1.156807e-4 |
GO:0060011 | Sertoli cell proliferation | 1.185746e-4 |
GO:0051252 | regulation of RNA metabolic process | 1.187124e-4 |
GO:0032649 | regulation of interferon-gamma production | 1.191623e-4 |
GO:0010501 | RNA secondary structure unwinding | 1.208597e-4 |
GO:0045779 | negative regulation of bone resorption | 1.224848e-4 |
GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation | 1.289606e-4 |
GO:0031348 | negative regulation of defense response | 1.299520e-4 |
GO:0046851 | negative regulation of bone remodeling | 1.319780e-4 |
GO:0044247 | cellular polysaccharide catabolic process | 1.322369e-4 |
GO:0009251 | glucan catabolic process | 1.322369e-4 |
GO:0042416 | dopamine biosynthetic process | 1.342569e-4 |
GO:0031623 | receptor internalization | 1.353713e-4 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.383391e-4 |
GO:0060113 | inner ear receptor cell differentiation | 1.390541e-4 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.404654e-4 |
GO:0006351 | transcription, DNA-dependent | 1.415504e-4 |
GO:0009968 | negative regulation of signal transduction | 1.422648e-4 |
GO:0002221 | pattern recognition receptor signaling pathway | 1.429527e-4 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.473398e-4 |
GO:0060749 | mammary gland alveolus development | 1.474845e-4 |
GO:0042483 | negative regulation of odontogenesis | 1.485772e-4 |
GO:0033693 | neurofilament bundle assembly | 1.485772e-4 |
GO:0071477 | cellular hypotonic salinity response | 1.506068e-4 |
GO:0060580 | ventral spinal cord interneuron fate determination | 1.506068e-4 |
GO:0003327 | type B pancreatic cell fate commitment | 1.506068e-4 |
GO:0048468 | cell development | 1.545830e-4 |
GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.550293e-4 |
GO:0042471 | ear morphogenesis | 1.587316e-4 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 1.595102e-4 |
GO:0007605 | sensory perception of sound | 1.633621e-4 |
GO:0065007 | biological regulation | 1.662624e-4 |
GO:0021536 | diencephalon development | 1.668543e-4 |
GO:0018243 | protein O-linked glycosylation via threonine | 1.674996e-4 |
GO:0071895 | odontoblast differentiation | 1.674996e-4 |
GO:0018242 | protein O-linked glycosylation via serine | 1.674996e-4 |
GO:0070838 | divalent metal ion transport | 1.677265e-4 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 1.691661e-4 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 1.691661e-4 |
GO:0090316 | positive regulation of intracellular protein transport | 1.719855e-4 |
GO:0060603 | mammary gland duct morphogenesis | 1.728877e-4 |
GO:0045200 | establishment of neuroblast polarity | 1.741729e-4 |
GO:0002175 | protein localization to paranode region of axon | 1.741729e-4 |
GO:0010837 | regulation of keratinocyte proliferation | 1.768431e-4 |
GO:0005980 | glycogen catabolic process | 1.811384e-4 |
GO:0048565 | digestive tract development | 1.839989e-4 |
GO:0070346 | positive regulation of fat cell proliferation | 1.858182e-4 |
GO:0006313 | transposition, DNA-mediated | 1.858182e-4 |
GO:0032642 | regulation of chemokine production | 1.866307e-4 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 1.877055e-4 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.889535e-4 |
GO:0007369 | gastrulation | 1.943931e-4 |
GO:0018342 | protein prenylation | 1.958319e-4 |
GO:0042490 | mechanoreceptor differentiation | 1.958439e-4 |
GO:0060594 | mammary gland specification | 1.969600e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.986921e-4 |
GO:0051924 | regulation of calcium ion transport | 1.989682e-4 |
GO:0014033 | neural crest cell differentiation | 2.024891e-4 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 2.042378e-4 |
GO:0043921 | modulation by host of viral transcription | 2.056245e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.089598e-4 |
GO:0030182 | neuron differentiation | 2.149390e-4 |
GO:0072511 | divalent inorganic cation transport | 2.155335e-4 |
GO:0035545 | determination of left/right asymmetry in nervous system | 2.196382e-4 |
GO:0061302 | smooth muscle cell-matrix adhesion | 2.196382e-4 |
GO:0045884 | regulation of survival gene product expression | 2.199955e-4 |
GO:0050884 | neuromuscular process controlling posture | 2.225641e-4 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 2.325538e-4 |
GO:0050877 | neurological system process | 2.338579e-4 |
GO:0022904 | respiratory electron transport chain | 2.352767e-4 |
GO:0070536 | protein K63-linked deubiquitination | 2.417718e-4 |
GO:0060019 | radial glial cell differentiation | 2.430106e-4 |
GO:0016198 | axon choice point recognition | 2.518857e-4 |
GO:0060255 | regulation of macromolecule metabolic process | 2.579875e-4 |
GO:0046716 | muscle cell homeostasis | 2.605047e-4 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 2.643078e-4 |
GO:0014074 | response to purine-containing compound | 2.648306e-4 |
GO:0055085 | transmembrane transport | 2.668007e-4 |
GO:0044060 | regulation of endocrine process | 2.678708e-4 |
GO:0031323 | regulation of cellular metabolic process | 2.688676e-4 |
GO:0033151 | V(D)J recombination | 2.698005e-4 |
GO:0072358 | cardiovascular system development | 2.750698e-4 |
GO:0030213 | hyaluronan biosynthetic process | 2.773767e-4 |
GO:0007610 | behavior | 2.805485e-4 |
GO:0010633 | negative regulation of epithelial cell migration | 2.817896e-4 |
GO:0060788 | ectodermal placode formation | 2.866755e-4 |
GO:0002758 | innate immune response-activating signal transduction | 2.915632e-4 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 2.961101e-4 |
GO:0001541 | ovarian follicle development | 2.970648e-4 |
GO:0048513 | organ development | 2.984111e-4 |
GO:2000026 | regulation of multicellular organismal development | 3.049556e-4 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 3.099405e-4 |
GO:0072003 | kidney rudiment formation | 3.183049e-4 |
GO:0060052 | neurofilament cytoskeleton organization | 3.235532e-4 |
GO:0048385 | regulation of retinoic acid receptor signaling pathway | 3.258907e-4 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 3.288274e-4 |
GO:0007565 | female pregnancy | 3.331161e-4 |
GO:0048709 | oligodendrocyte differentiation | 3.337001e-4 |
GO:0045088 | regulation of innate immune response | 3.356239e-4 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 3.381344e-4 |
GO:0060088 | auditory receptor cell stereocilium organization | 3.381344e-4 |
GO:0050806 | positive regulation of synaptic transmission | 3.410226e-4 |
GO:0006809 | nitric oxide biosynthetic process | 3.417540e-4 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.461121e-4 |
GO:0070375 | BMK cascade | 3.490407e-4 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 3.490407e-4 |
GO:0021827 | postnatal olfactory bulb interneuron migration | 3.490407e-4 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 3.503737e-4 |
GO:0044091 | membrane biogenesis | 3.512964e-4 |
GO:0003008 | system process | 3.542609e-4 |
GO:0006638 | neutral lipid metabolic process | 3.553022e-4 |
GO:0006816 | calcium ion transport | 3.582186e-4 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 3.594716e-4 |
GO:0048729 | tissue morphogenesis | 3.634697e-4 |
GO:0014032 | neural crest cell development | 3.642289e-4 |
GO:0007275 | multicellular organismal development | 3.703051e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 3.707916e-4 |
GO:0070848 | response to growth factor stimulus | 3.860065e-4 |
GO:0043392 | negative regulation of DNA binding | 3.874841e-4 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 3.924207e-4 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 3.924207e-4 |
GO:0039003 | pronephric field specification | 3.924207e-4 |
GO:0007498 | mesoderm development | 4.003093e-4 |
GO:0071899 | negative regulation of estrogen receptor binding | 4.055218e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 4.137892e-4 |
GO:0051066 | dihydrobiopterin metabolic process | 4.137892e-4 |
GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 4.144114e-4 |
GO:0055080 | cation homeostasis | 4.186501e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 4.258101e-4 |
GO:0001568 | blood vessel development | 4.265008e-4 |
GO:0006639 | acylglycerol metabolic process | 4.287878e-4 |
GO:0007166 | cell surface receptor linked signaling pathway | 4.293161e-4 |
GO:0002093 | auditory receptor cell morphogenesis | 4.294357e-4 |
GO:0035330 | regulation of hippo signaling cascade | 4.389550e-4 |
GO:2000241 | regulation of reproductive process | 4.431286e-4 |
GO:0032703 | negative regulation of interleukin-2 production | 4.468499e-4 |
GO:0046677 | response to antibiotic | 4.561682e-4 |
GO:0033153 | T cell receptor V(D)J recombination | 4.654281e-4 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 4.674962e-4 |
GO:0090068 | positive regulation of cell cycle process | 4.793831e-4 |
GO:0030223 | neutrophil differentiation | 4.833151e-4 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 4.844645e-4 |
GO:0010033 | response to organic substance | 4.883856e-4 |
GO:0032331 | negative regulation of chondrocyte differentiation | 4.888274e-4 |
GO:0051145 | smooth muscle cell differentiation | 4.932021e-4 |
GO:0090276 | regulation of peptide hormone secretion | 4.966583e-4 |
GO:0048856 | anatomical structure development | 4.971951e-4 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 4.981109e-4 |
GO:0006571 | tyrosine biosynthetic process | 4.981109e-4 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 4.996292e-4 |
GO:0061029 | eyelid development in camera-type eye | 5.023336e-4 |
GO:0022410 | circadian sleep/wake cycle process | 5.023336e-4 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 5.023824e-4 |
GO:0048341 | paraxial mesoderm formation | 5.040217e-4 |
GO:0048522 | positive regulation of cellular process | 5.053898e-4 |
GO:0015789 | UDP-N-acetylgalactosamine transport | 5.110631e-4 |
GO:0015787 | UDP-glucuronic acid transport | 5.110631e-4 |
GO:0002757 | immune response-activating signal transduction | 5.159186e-4 |
GO:0090361 | regulation of platelet-derived growth factor production | 5.166459e-4 |
GO:0072221 | metanephric distal convoluted tubule development | 5.266593e-4 |
GO:0032388 | positive regulation of intracellular transport | 5.312283e-4 |
GO:0032409 | regulation of transporter activity | 5.317717e-4 |
GO:0060523 | prostate epithelial cord elongation | 5.356898e-4 |
GO:0051241 | negative regulation of multicellular organismal process | 5.368275e-4 |
GO:0032876 | negative regulation of DNA endoreduplication | 5.463902e-4 |
GO:0002384 | hepatic immune response | 5.463902e-4 |
GO:0007379 | segment specification | 5.473095e-4 |
GO:0010632 | regulation of epithelial cell migration | 5.538149e-4 |
GO:0031394 | positive regulation of prostaglandin biosynthetic process | 5.541477e-4 |
GO:0071310 | cellular response to organic substance | 5.641169e-4 |
GO:0090074 | negative regulation of protein homodimerization activity | 5.641435e-4 |
GO:0009790 | embryo development | 5.642367e-4 |
GO:0060525 | prostate glandular acinus development | 5.643926e-4 |
GO:0045638 | negative regulation of myeloid cell differentiation | 5.740469e-4 |
GO:0060745 | mammary gland branching involved in pregnancy | 5.970237e-4 |
GO:0051480 | cytosolic calcium ion homeostasis | 6.051941e-4 |
GO:0048066 | developmental pigmentation | 6.056776e-4 |
GO:0043201 | response to leucine | 6.076619e-4 |
GO:0048512 | circadian behavior | 6.231391e-4 |
GO:0030879 | mammary gland development | 6.339540e-4 |
GO:0032092 | positive regulation of protein binding | 6.344348e-4 |
GO:0003002 | regionalization | 6.347224e-4 |
GO:0032386 | regulation of intracellular transport | 6.378867e-4 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 6.424767e-4 |
GO:0032108 | negative regulation of response to nutrient levels | 6.461325e-4 |
GO:0021535 | cell migration in hindbrain | 6.583052e-4 |
GO:0060839 | endothelial cell fate commitment | 6.643097e-4 |
GO:0046146 | tetrahydrobiopterin metabolic process | 6.643097e-4 |
GO:0001944 | vasculature development | 6.659447e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 6.678858e-4 |
GO:0032870 | cellular response to hormone stimulus | 6.743550e-4 |
GO:0080090 | regulation of primary metabolic process | 6.883955e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 6.992599e-4 |
GO:0048713 | regulation of oligodendrocyte differentiation | 6.996494e-4 |
GO:0015721 | bile acid and bile salt transport | 7.053311e-4 |
GO:0043112 | receptor metabolic process | 7.092501e-4 |
GO:2000659 | regulation of interleukin-1-mediated signaling pathway | 7.137859e-4 |
GO:0048280 | vesicle fusion with Golgi apparatus | 7.188364e-4 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 7.188364e-4 |
GO:0072378 | blood coagulation, fibrin clot formation | 7.190071e-4 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 7.207164e-4 |
GO:0032981 | mitochondrial respiratory chain complex I assembly | 7.299096e-4 |
GO:0001503 | ossification | 7.483240e-4 |
GO:0015820 | leucine transport | 7.488667e-4 |
GO:0008612 | peptidyl-lysine modification to hypusine | 7.488667e-4 |
GO:0032774 | RNA biosynthetic process | 7.519094e-4 |
GO:0032502 | developmental process | 7.776555e-4 |
GO:0035112 | genitalia morphogenesis | 7.779658e-4 |
GO:0045727 | positive regulation of translation | 7.943890e-4 |
GO:0006641 | triglyceride metabolic process | 8.064742e-4 |
GO:0007389 | pattern specification process | 8.173973e-4 |
GO:0070365 | hepatocyte differentiation | 8.341299e-4 |
GO:0045333 | cellular respiration | 8.366893e-4 |
GO:0034762 | regulation of transmembrane transport | 8.428968e-4 |
GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain | 8.471115e-4 |
GO:0042745 | circadian sleep/wake cycle | 8.575307e-4 |
GO:0048660 | regulation of smooth muscle cell proliferation | 8.586321e-4 |
GO:0044344 | cellular response to fibroblast growth factor stimulus | 8.641565e-4 |
GO:0009068 | aspartate family amino acid catabolic process | 8.664911e-4 |
GO:0045639 | positive regulation of myeloid cell differentiation | 8.700142e-4 |
GO:0060828 | regulation of canonical Wnt receptor signaling pathway | 8.803232e-4 |
GO:0030854 | positive regulation of granulocyte differentiation | 8.942086e-4 |
GO:0043490 | malate-aspartate shuttle | 8.949530e-4 |
GO:0048666 | neuron development | 8.999729e-4 |
GO:0007494 | midgut development | 9.034617e-4 |
GO:0072017 | distal tubule development | 9.084669e-4 |
GO:0045356 | positive regulation of interferon-alpha biosynthetic process | 9.086646e-4 |
GO:0045110 | intermediate filament bundle assembly | 9.086646e-4 |
GO:0002764 | immune response-regulating signaling pathway | 9.107540e-4 |
GO:0031349 | positive regulation of defense response | 9.189094e-4 |
GO:0050931 | pigment cell differentiation | 9.282091e-4 |
GO:0042095 | interferon-gamma biosynthetic process | 9.284159e-4 |
GO:0033627 | cell adhesion mediated by integrin | 9.436182e-4 |
GO:0001655 | urogenital system development | 9.477201e-4 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 9.722688e-4 |
GO:0030111 | regulation of Wnt receptor signaling pathway | 9.767573e-4 |
GO:0002036 | regulation of L-glutamate transport | 9.788682e-4 |
GO:0010467 | gene expression | 9.966951e-4 |
GO:0010243 | response to organic nitrogen | 1.007635e-3 |
GO:0040008 | regulation of growth | 1.048109e-3 |
GO:0006885 | regulation of pH | 1.083388e-3 |
GO:0032965 | regulation of collagen biosynthetic process | 1.095751e-3 |
GO:0006111 | regulation of gluconeogenesis | 1.095751e-3 |
GO:0001525 | angiogenesis | 1.127994e-3 |
GO:0060068 | vagina development | 1.135612e-3 |
GO:0048731 | system development | 1.142105e-3 |
GO:0071985 | multivesicular body sorting pathway | 1.163589e-3 |
GO:0007622 | rhythmic behavior | 1.164466e-3 |
GO:0042491 | auditory receptor cell differentiation | 1.173710e-3 |
GO:0000052 | citrulline metabolic process | 1.186282e-3 |
GO:0048087 | positive regulation of developmental pigmentation | 1.193257e-3 |
GO:0035987 | endodermal cell differentiation | 1.193257e-3 |
GO:0046580 | negative regulation of Ras protein signal transduction | 1.194168e-3 |
GO:0002791 | regulation of peptide secretion | 1.205737e-3 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 1.218967e-3 |
GO:0034104 | negative regulation of tissue remodeling | 1.228776e-3 |
GO:0048878 | chemical homeostasis | 1.260233e-3 |
GO:0043523 | regulation of neuron apoptosis | 1.262599e-3 |
GO:0016070 | RNA metabolic process | 1.279956e-3 |
GO:0033629 | negative regulation of cell adhesion mediated by integrin | 1.286212e-3 |
GO:0007597 | blood coagulation, intrinsic pathway | 1.294833e-3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 1.297594e-3 |
GO:0048880 | sensory system development | 1.297976e-3 |
GO:0032879 | regulation of localization | 1.345682e-3 |
GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep | 1.367815e-3 |
GO:0048496 | maintenance of organ identity | 1.403992e-3 |
GO:0045063 | T-helper 1 cell differentiation | 1.408958e-3 |
GO:0051046 | regulation of secretion | 1.426044e-3 |
GO:0048562 | embryonic organ morphogenesis | 1.427963e-3 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 1.428473e-3 |
GO:0048762 | mesenchymal cell differentiation | 1.430513e-3 |
GO:0033157 | regulation of intracellular protein transport | 1.447286e-3 |
GO:0031989 | bombesin receptor signaling pathway | 1.454749e-3 |
GO:0032854 | positive regulation of Rap GTPase activity | 1.465520e-3 |
GO:0006073 | cellular glucan metabolic process | 1.480601e-3 |
GO:0030518 | steroid hormone receptor signaling pathway | 1.498740e-3 |
GO:0010897 | negative regulation of triglyceride catabolic process | 1.499260e-3 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 1.499260e-3 |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1.514120e-3 |
GO:0002262 | myeloid cell homeostasis | 1.528365e-3 |
GO:0032768 | regulation of monooxygenase activity | 1.534895e-3 |
GO:0019896 | axon transport of mitochondrion | 1.542120e-3 |
GO:2000366 | positive regulation of STAT protein import into nucleus | 1.554471e-3 |
GO:0070091 | glucagon secretion | 1.554471e-3 |
GO:0008154 | actin polymerization or depolymerization | 1.567988e-3 |
GO:0021510 | spinal cord development | 1.571124e-3 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 1.571900e-3 |
GO:0021932 | hindbrain radial glia guided cell migration | 1.583576e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 1.587882e-3 |
GO:0006097 | glyoxylate cycle | 1.587882e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050789 | regulation of biological process | 1.699785e-12 |
GO:0050794 | regulation of cellular process | 3.546506e-12 |
GO:0048732 | gland development | 8.436334e-12 |
GO:0007165 | signal transduction | 1.196871e-10 |
GO:0007275 | multicellular organismal development | 2.182688e-10 |
GO:0051716 | cellular response to stimulus | 2.297441e-10 |
GO:0050896 | response to stimulus | 2.409117e-10 |
GO:0048731 | system development | 3.089972e-10 |
GO:0023052 | signaling | 3.769693e-10 |
GO:0031326 | regulation of cellular biosynthetic process | 4.556436e-10 |
GO:0048518 | positive regulation of biological process | 4.899847e-10 |
GO:0032501 | multicellular organismal process | 6.165244e-10 |
GO:0048522 | positive regulation of cellular process | 9.669386e-10 |
GO:0051050 | positive regulation of transport | 1.050895e-9 |
GO:0065007 | biological regulation | 1.100630e-9 |
GO:0001655 | urogenital system development | 1.135042e-9 |
GO:0009889 | regulation of biosynthetic process | 1.244103e-9 |
GO:0010646 | regulation of cell communication | 1.533910e-9 |
GO:0048513 | organ development | 3.004004e-9 |
GO:0009888 | tissue development | 3.012636e-9 |
GO:0009605 | response to external stimulus | 4.406526e-9 |
GO:0048869 | cellular developmental process | 5.301242e-9 |
GO:0043409 | negative regulation of MAPKKK cascade | 5.822222e-9 |
GO:0014911 | positive regulation of smooth muscle cell migration | 6.250193e-9 |
GO:0030154 | cell differentiation | 7.537031e-9 |
GO:0071670 | smooth muscle cell chemotaxis | 8.283529e-9 |
GO:0060981 | cell migration involved in coronary angiogenesis | 8.283529e-9 |
GO:0016579 | protein deubiquitination | 9.144772e-9 |
GO:0022612 | gland morphogenesis | 1.288603e-8 |
GO:0046883 | regulation of hormone secretion | 1.307428e-8 |
GO:0051047 | positive regulation of secretion | 1.403414e-8 |
GO:2000573 | positive regulation of DNA biosynthetic process | 1.451801e-8 |
GO:0031323 | regulation of cellular metabolic process | 1.753004e-8 |
GO:0072203 | cell proliferation involved in metanephros development | 1.771845e-8 |
GO:0032502 | developmental process | 1.863477e-8 |
GO:0035270 | endocrine system development | 2.416018e-8 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 3.314032e-8 |
GO:0060255 | regulation of macromolecule metabolic process | 3.497598e-8 |
GO:0048856 | anatomical structure development | 3.859592e-8 |
GO:0031167 | rRNA methylation | 3.996720e-8 |
GO:0007154 | cell communication | 4.278871e-8 |
GO:0010647 | positive regulation of cell communication | 4.361905e-8 |
GO:0010556 | regulation of macromolecule biosynthetic process | 4.644082e-8 |
GO:0002244 | hemopoietic progenitor cell differentiation | 5.054866e-8 |
GO:0007399 | nervous system development | 5.930153e-8 |
GO:0030850 | prostate gland development | 6.073904e-8 |
GO:0019222 | regulation of metabolic process | 6.210780e-8 |
GO:0061302 | smooth muscle cell-matrix adhesion | 6.630888e-8 |
GO:0046887 | positive regulation of hormone secretion | 7.045989e-8 |
GO:0051171 | regulation of nitrogen compound metabolic process | 7.516191e-8 |
GO:0001818 | negative regulation of cytokine production | 7.876271e-8 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 8.859765e-8 |
GO:0051240 | positive regulation of multicellular organismal process | 1.079500e-7 |
GO:0048699 | generation of neurons | 1.350311e-7 |
GO:0023056 | positive regulation of signaling | 1.404333e-7 |
GO:0051252 | regulation of RNA metabolic process | 1.456180e-7 |
GO:0080090 | regulation of primary metabolic process | 1.456424e-7 |
GO:0022008 | neurogenesis | 1.649300e-7 |
GO:0002320 | lymphoid progenitor cell differentiation | 1.655656e-7 |
GO:0007417 | central nervous system development | 2.529966e-7 |
GO:0023051 | regulation of signaling | 2.642271e-7 |
GO:0030182 | neuron differentiation | 2.814288e-7 |
GO:0072111 | cell proliferation involved in kidney development | 3.270971e-7 |
GO:0000154 | rRNA modification | 3.329572e-7 |
GO:0014910 | regulation of smooth muscle cell migration | 3.636539e-7 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 3.928261e-7 |
GO:0070887 | cellular response to chemical stimulus | 4.077742e-7 |
GO:0009967 | positive regulation of signal transduction | 4.208808e-7 |
GO:0006935 | chemotaxis | 4.427083e-7 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 4.746637e-7 |
GO:0001501 | skeletal system development | 4.961591e-7 |
GO:0042330 | taxis | 5.667412e-7 |
GO:0048584 | positive regulation of response to stimulus | 6.417091e-7 |
GO:0010627 | regulation of intracellular protein kinase cascade | 6.548530e-7 |
GO:0007166 | cell surface receptor linked signaling pathway | 6.780994e-7 |
GO:0032879 | regulation of localization | 6.957774e-7 |
GO:0051049 | regulation of transport | 7.000919e-7 |
GO:0006355 | regulation of transcription, DNA-dependent | 7.176318e-7 |
GO:0035904 | aorta development | 8.263059e-7 |
GO:0030282 | bone mineralization | 8.921744e-7 |
GO:0060429 | epithelium development | 9.155804e-7 |
GO:0090068 | positive regulation of cell cycle process | 1.089142e-6 |
GO:0048583 | regulation of response to stimulus | 1.148814e-6 |
GO:0002009 | morphogenesis of an epithelium | 1.216284e-6 |
GO:0072001 | renal system development | 1.222081e-6 |
GO:0060840 | artery development | 1.280047e-6 |
GO:0030879 | mammary gland development | 1.506941e-6 |
GO:0048660 | regulation of smooth muscle cell proliferation | 1.645334e-6 |
GO:0035239 | tube morphogenesis | 1.675209e-6 |
GO:0051896 | regulation of protein kinase B signaling cascade | 1.724361e-6 |
GO:0060012 | synaptic transmission, glycinergic | 1.797401e-6 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 1.974296e-6 |
GO:0072006 | nephron development | 2.133658e-6 |
GO:0000188 | inactivation of MAPK activity | 2.141698e-6 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.172069e-6 |
GO:0009893 | positive regulation of metabolic process | 2.244002e-6 |
GO:0009653 | anatomical structure morphogenesis | 2.271161e-6 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2.306748e-6 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 2.310981e-6 |
GO:0051239 | regulation of multicellular organismal process | 2.432315e-6 |
GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation | 2.479863e-6 |
GO:0031325 | positive regulation of cellular metabolic process | 2.546874e-6 |
GO:0008284 | positive regulation of cell proliferation | 2.547326e-6 |
GO:0003002 | regionalization | 2.547805e-6 |
GO:0034261 | negative regulation of Ras GTPase activity | 2.557440e-6 |
GO:0043407 | negative regulation of MAP kinase activity | 2.798403e-6 |
GO:0042327 | positive regulation of phosphorylation | 3.135711e-6 |
GO:0016070 | RNA metabolic process | 3.183793e-6 |
GO:0010468 | regulation of gene expression | 3.305303e-6 |
GO:0070646 | protein modification by small protein removal | 3.412113e-6 |
GO:0072070 | loop of Henle development | 3.670894e-6 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 3.715839e-6 |
GO:0003006 | developmental process involved in reproduction | 3.742573e-6 |
GO:0048608 | reproductive structure development | 3.838862e-6 |
GO:0032774 | RNA biosynthetic process | 4.002784e-6 |
GO:0072073 | kidney epithelium development | 4.131832e-6 |
GO:0031018 | endocrine pancreas development | 4.323978e-6 |
GO:0043148 | mitotic spindle stabilization | 4.723620e-6 |
GO:0090276 | regulation of peptide hormone secretion | 4.929977e-6 |
GO:0006351 | transcription, DNA-dependent | 4.978425e-6 |
GO:0043032 | positive regulation of macrophage activation | 4.981963e-6 |
GO:0043303 | mast cell degranulation | 5.341625e-6 |
GO:0060442 | branching involved in prostate gland morphogenesis | 5.414849e-6 |
GO:0010595 | positive regulation of endothelial cell migration | 5.668267e-6 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 5.824933e-6 |
GO:0072009 | nephron epithelium development | 6.021565e-6 |
GO:0060512 | prostate gland morphogenesis | 6.308111e-6 |
GO:0072080 | nephron tubule development | 6.419793e-6 |
GO:0072176 | nephric duct development | 7.487632e-6 |
GO:0021936 | regulation of cerebellar granule cell precursor proliferation | 7.641181e-6 |
GO:0045937 | positive regulation of phosphate metabolic process | 7.935585e-6 |
GO:0032695 | negative regulation of interleukin-12 production | 8.003224e-6 |
GO:0015939 | pantothenate metabolic process | 8.239414e-6 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.296435e-6 |
GO:0051602 | response to electrical stimulus | 8.820139e-6 |
GO:0043374 | CD8-positive, alpha-beta T cell differentiation | 8.871628e-6 |
GO:0072017 | distal tubule development | 9.028767e-6 |
GO:0042127 | regulation of cell proliferation | 9.077567e-6 |
GO:0072178 | nephric duct morphogenesis | 9.125763e-6 |
GO:0060443 | mammary gland morphogenesis | 9.393985e-6 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.497476e-6 |
GO:0030518 | steroid hormone receptor signaling pathway | 9.747979e-6 |
GO:0007548 | sex differentiation | 1.011431e-5 |
GO:0009891 | positive regulation of biosynthetic process | 1.011907e-5 |
GO:0060244 | negative regulation of cell proliferation involved in contact inhibition | 1.049329e-5 |
GO:0032270 | positive regulation of cellular protein metabolic process | 1.057678e-5 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 1.077912e-5 |
GO:0009952 | anterior/posterior pattern specification | 1.086542e-5 |
GO:0002520 | immune system development | 1.106786e-5 |
GO:0021985 | neurohypophysis development | 1.114840e-5 |
GO:0071158 | positive regulation of cell cycle arrest | 1.214631e-5 |
GO:0035674 | tricarboxylic acid transmembrane transport | 1.215115e-5 |
GO:0048096 | chromatin-mediated maintenance of transcription | 1.227707e-5 |
GO:0043414 | macromolecule methylation | 1.260272e-5 |
GO:0060259 | regulation of feeding behavior | 1.307485e-5 |
GO:0031401 | positive regulation of protein modification process | 1.338106e-5 |
GO:0009966 | regulation of signal transduction | 1.341058e-5 |
GO:0061326 | renal tubule development | 1.462578e-5 |
GO:0048534 | hemopoietic or lymphoid organ development | 1.603946e-5 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.610556e-5 |
GO:0060740 | prostate gland epithelium morphogenesis | 1.631155e-5 |
GO:2000507 | positive regulation of energy homeostasis | 1.638037e-5 |
GO:2000253 | positive regulation of feeding behavior | 1.638037e-5 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 1.647908e-5 |
GO:0007346 | regulation of mitotic cell cycle | 1.660649e-5 |
GO:0060690 | epithelial cell differentiation involved in salivary gland development | 1.757039e-5 |
GO:0048729 | tissue morphogenesis | 1.816402e-5 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 1.845736e-5 |
GO:0071363 | cellular response to growth factor stimulus | 1.872030e-5 |
GO:0048589 | developmental growth | 1.887816e-5 |
GO:0048485 | sympathetic nervous system development | 2.011533e-5 |
GO:0031328 | positive regulation of cellular biosynthetic process | 2.107245e-5 |
GO:0030513 | positive regulation of BMP signaling pathway | 2.195110e-5 |
GO:0007420 | brain development | 2.228653e-5 |
GO:0060326 | cell chemotaxis | 2.240177e-5 |
GO:0030097 | hemopoiesis | 2.259315e-5 |
GO:0048598 | embryonic morphogenesis | 2.272034e-5 |
GO:0010226 | response to lithium ion | 2.313592e-5 |
GO:0071478 | cellular response to radiation | 2.329600e-5 |
GO:0032203 | telomere formation via telomerase | 2.361640e-5 |
GO:0016477 | cell migration | 2.392035e-5 |
GO:0002791 | regulation of peptide secretion | 2.428726e-5 |
GO:0001822 | kidney development | 2.524415e-5 |
GO:0007389 | pattern specification process | 2.587207e-5 |
GO:0044260 | cellular macromolecule metabolic process | 2.689364e-5 |
GO:0043170 | macromolecule metabolic process | 2.693516e-5 |
GO:0042221 | response to chemical stimulus | 2.707963e-5 |
GO:0072277 | metanephric glomerular capillary formation | 2.769775e-5 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 2.795394e-5 |
GO:2000147 | positive regulation of cell motility | 2.859230e-5 |
GO:0048013 | ephrin receptor signaling pathway | 2.888260e-5 |
GO:0051241 | negative regulation of multicellular organismal process | 2.994447e-5 |
GO:0060164 | regulation of timing of neuron differentiation | 3.204753e-5 |
GO:0051046 | regulation of secretion | 3.320286e-5 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase cascade | 3.356513e-5 |
GO:0006479 | protein methylation | 3.403415e-5 |
GO:0090277 | positive regulation of peptide hormone secretion | 3.573533e-5 |
GO:0010604 | positive regulation of macromolecule metabolic process | 3.674089e-5 |
GO:0050796 | regulation of insulin secretion | 3.748067e-5 |
GO:0035909 | aorta morphogenesis | 3.800327e-5 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 3.817012e-5 |
GO:0048844 | artery morphogenesis | 3.891932e-5 |
GO:0071779 | G1/S transition checkpoint | 3.986481e-5 |
GO:0042256 | mature ribosome assembly | 4.213915e-5 |
GO:0070588 | calcium ion transmembrane transport | 4.299489e-5 |
GO:0001709 | cell fate determination | 4.428402e-5 |
GO:0014048 | regulation of glutamate secretion | 4.514489e-5 |
GO:0021979 | hypothalamus cell differentiation | 4.595072e-5 |
GO:0048806 | genitalia development | 4.605886e-5 |
GO:0002328 | pro-B cell differentiation | 4.615872e-5 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.733513e-5 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 4.834506e-5 |
GO:0001656 | metanephros development | 4.890764e-5 |
GO:0014049 | positive regulation of glutamate secretion | 4.908873e-5 |
GO:0030335 | positive regulation of cell migration | 4.925922e-5 |
GO:0050847 | progesterone receptor signaling pathway | 5.115873e-5 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 5.277705e-5 |
GO:0048745 | smooth muscle tissue development | 5.356467e-5 |
GO:0051272 | positive regulation of cellular component movement | 5.457603e-5 |
GO:0071482 | cellular response to light stimulus | 5.556614e-5 |
GO:0061005 | cell differentiation involved in kidney development | 5.871835e-5 |
GO:0009790 | embryo development | 5.955244e-5 |
GO:0032024 | positive regulation of insulin secretion | 5.956028e-5 |
GO:0040017 | positive regulation of locomotion | 6.348060e-5 |
GO:0035295 | tube development | 6.407206e-5 |
GO:0010594 | regulation of endothelial cell migration | 6.449689e-5 |
GO:0007442 | hindgut morphogenesis | 6.457863e-5 |
GO:0002793 | positive regulation of peptide secretion | 6.730159e-5 |
GO:0043030 | regulation of macrophage activation | 7.136914e-5 |
GO:0090361 | regulation of platelet-derived growth factor production | 7.164902e-5 |
GO:0030510 | regulation of BMP signaling pathway | 7.225169e-5 |
GO:0072104 | glomerular capillary formation | 7.264844e-5 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 7.264844e-5 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 7.720511e-5 |
GO:0010628 | positive regulation of gene expression | 8.068883e-5 |
GO:0034259 | negative regulation of Rho GTPase activity | 8.202741e-5 |
GO:0008283 | cell proliferation | 8.231020e-5 |
GO:0042706 | eye photoreceptor cell fate commitment | 8.388661e-5 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8.429622e-5 |
GO:0030522 | intracellular receptor mediated signaling pathway | 8.615512e-5 |
GO:0043408 | regulation of MAPKKK cascade | 8.742949e-5 |
GO:0002687 | positive regulation of leukocyte migration | 9.251402e-5 |
GO:0060973 | cell migration involved in heart development | 9.317577e-5 |
GO:0001934 | positive regulation of protein phosphorylation | 9.350654e-5 |
GO:0090304 | nucleic acid metabolic process | 9.383085e-5 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 9.499853e-5 |
GO:0014066 | regulation of phosphatidylinositol 3-kinase cascade | 1.013476e-4 |
GO:0060056 | mammary gland involution | 1.015472e-4 |
GO:0021955 | central nervous system neuron axonogenesis | 1.020738e-4 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 1.039786e-4 |
GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine | 1.041417e-4 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 1.079319e-4 |
GO:0009416 | response to light stimulus | 1.080987e-4 |
GO:0021965 | spinal cord ventral commissure morphogenesis | 1.134773e-4 |
GO:0030574 | collagen catabolic process | 1.158178e-4 |
GO:0070848 | response to growth factor stimulus | 1.192242e-4 |
GO:0032844 | regulation of homeostatic process | 1.192383e-4 |
GO:0072239 | metanephric glomerulus vasculature development | 1.200111e-4 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.217824e-4 |
GO:0048259 | regulation of receptor-mediated endocytosis | 1.293710e-4 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.306400e-4 |
GO:0060689 | cell differentiation involved in salivary gland development | 1.380733e-4 |
GO:0001985 | negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure | 1.380733e-4 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 1.399968e-4 |
GO:0006805 | xenobiotic metabolic process | 1.432242e-4 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1.484697e-4 |
GO:0043009 | chordate embryonic development | 1.510787e-4 |
GO:0042220 | response to cocaine | 1.519714e-4 |
GO:0072102 | glomerulus morphogenesis | 1.535272e-4 |
GO:0016571 | histone methylation | 1.556846e-4 |
GO:2000177 | regulation of neural precursor cell proliferation | 1.567744e-4 |
GO:0033083 | regulation of immature T cell proliferation | 1.628153e-4 |
GO:0021915 | neural tube development | 1.633032e-4 |
GO:0060279 | positive regulation of ovulation | 1.689292e-4 |
GO:0060563 | neuroepithelial cell differentiation | 1.698544e-4 |
GO:0050673 | epithelial cell proliferation | 1.734586e-4 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 1.755296e-4 |
GO:0035710 | CD4-positive, alpha-beta T cell activation | 1.792943e-4 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 1.812067e-4 |
GO:0002376 | immune system process | 1.832936e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 1.838260e-4 |
GO:0051247 | positive regulation of protein metabolic process | 1.864412e-4 |
GO:0010001 | glial cell differentiation | 1.889614e-4 |
GO:0061036 | positive regulation of cartilage development | 1.972951e-4 |
GO:0051383 | kinetochore organization | 2.045213e-4 |
GO:0071622 | regulation of granulocyte chemotaxis | 2.080826e-4 |
GO:0001817 | regulation of cytokine production | 2.089155e-4 |
GO:0045137 | development of primary sexual characteristics | 2.128874e-4 |
GO:0060341 | regulation of cellular localization | 2.152660e-4 |
GO:0009607 | response to biotic stimulus | 2.220682e-4 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 2.231802e-4 |
GO:0072179 | nephric duct formation | 2.306208e-4 |
GO:0061004 | pattern specification involved in kidney development | 2.306208e-4 |
GO:0051382 | kinetochore assembly | 2.341173e-4 |
GO:0034644 | cellular response to UV | 2.344827e-4 |
GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 2.370391e-4 |
GO:0003357 | noradrenergic neuron differentiation | 2.370478e-4 |
GO:0015732 | prostaglandin transport | 2.376636e-4 |
GO:0035112 | genitalia morphogenesis | 2.401393e-4 |
GO:0048389 | intermediate mesoderm development | 2.407105e-4 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 2.407105e-4 |
GO:0035441 | cell migration involved in vasculogenesis | 2.407105e-4 |
GO:0014909 | smooth muscle cell migration | 2.407105e-4 |
GO:0033598 | mammary gland epithelial cell proliferation | 2.461777e-4 |
GO:0035993 | deltoid tuberosity development | 2.512586e-4 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 2.534958e-4 |
GO:0014904 | myotube cell development | 2.542904e-4 |
GO:0010740 | positive regulation of intracellular protein kinase cascade | 2.580326e-4 |
GO:0046660 | female sex differentiation | 2.676437e-4 |
GO:0032963 | collagen metabolic process | 2.732133e-4 |
GO:0034260 | negative regulation of GTPase activity | 2.781823e-4 |
GO:0032259 | methylation | 2.805996e-4 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.837593e-4 |
GO:0048630 | skeletal muscle tissue growth | 2.839239e-4 |
GO:0035910 | ascending aorta morphogenesis | 2.841667e-4 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 2.841667e-4 |
GO:0050863 | regulation of T cell activation | 2.880251e-4 |
GO:0045055 | regulated secretory pathway | 3.032218e-4 |
GO:0032202 | telomere assembly | 3.049204e-4 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 3.104582e-4 |
GO:0043299 | leukocyte degranulation | 3.117601e-4 |
GO:0048483 | autonomic nervous system development | 3.129036e-4 |
GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 3.131063e-4 |
GO:2000505 | regulation of energy homeostasis | 3.276409e-4 |
GO:0071635 | negative regulation of transforming growth factor beta production | 3.317911e-4 |
GO:0043587 | tongue morphogenesis | 3.343779e-4 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.356456e-4 |
GO:0050867 | positive regulation of cell activation | 3.358028e-4 |
GO:0002444 | myeloid leukocyte mediated immunity | 3.399791e-4 |
GO:0071285 | cellular response to lithium ion | 3.417199e-4 |
GO:0032689 | negative regulation of interferon-gamma production | 3.417199e-4 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 3.508466e-4 |
GO:0072180 | mesonephric duct morphogenesis | 3.519239e-4 |
GO:0061056 | sclerotome development | 3.519239e-4 |
GO:0034284 | response to monosaccharide stimulus | 3.526689e-4 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 3.673643e-4 |
GO:0036006 | cellular response to macrophage colony-stimulating factor stimulus | 3.673956e-4 |
GO:0030316 | osteoclast differentiation | 3.696875e-4 |
GO:0006807 | nitrogen compound metabolic process | 3.703582e-4 |
GO:0016569 | covalent chromatin modification | 3.766927e-4 |
GO:0044060 | regulation of endocrine process | 3.774696e-4 |
GO:0048519 | negative regulation of biological process | 3.795634e-4 |
GO:0034767 | positive regulation of ion transmembrane transport | 3.826883e-4 |
GO:0045453 | bone resorption | 3.857629e-4 |
GO:0050798 | activated T cell proliferation | 3.869887e-4 |
GO:0010460 | positive regulation of heart rate | 3.879912e-4 |
GO:0072175 | epithelial tube formation | 3.941528e-4 |
GO:0009314 | response to radiation | 3.953574e-4 |
GO:0072224 | metanephric glomerulus development | 4.034059e-4 |
GO:0015746 | citrate transport | 4.054124e-4 |
GO:0071397 | cellular response to cholesterol | 4.099538e-4 |
GO:0032835 | glomerulus development | 4.165057e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 4.171190e-4 |
GO:0018022 | peptidyl-lysine methylation | 4.228422e-4 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 4.322274e-4 |
GO:0040007 | growth | 4.366948e-4 |
GO:0051973 | positive regulation of telomerase activity | 4.428039e-4 |
GO:0040011 | locomotion | 4.490857e-4 |
GO:0048505 | regulation of timing of cell differentiation | 4.677047e-4 |
GO:0007493 | endodermal cell fate determination | 4.726803e-4 |
GO:0007093 | mitotic cell cycle checkpoint | 4.728029e-4 |
GO:0051246 | regulation of protein metabolic process | 4.743410e-4 |
GO:0050865 | regulation of cell activation | 4.793636e-4 |
GO:0045165 | cell fate commitment | 4.823005e-4 |
GO:0043069 | negative regulation of programmed cell death | 4.945357e-4 |
GO:0048705 | skeletal system morphogenesis | 4.952319e-4 |
GO:0071310 | cellular response to organic substance | 4.955156e-4 |
GO:0009746 | response to hexose stimulus | 4.977438e-4 |
GO:0050870 | positive regulation of T cell activation | 5.007771e-4 |
GO:0033091 | positive regulation of immature T cell proliferation | 5.036992e-4 |
GO:0030217 | T cell differentiation | 5.161752e-4 |
GO:0044238 | primary metabolic process | 5.181164e-4 |
GO:0060157 | urinary bladder development | 5.227170e-4 |
GO:0045765 | regulation of angiogenesis | 5.237150e-4 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 5.346885e-4 |
GO:0032268 | regulation of cellular protein metabolic process | 5.387036e-4 |
GO:0033240 | positive regulation of cellular amine metabolic process | 5.403915e-4 |
GO:0048771 | tissue remodeling | 5.422946e-4 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 5.439544e-4 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 5.439544e-4 |
GO:0021952 | central nervous system projection neuron axonogenesis | 5.554811e-4 |
GO:0045161 | neuronal ion channel clustering | 5.561752e-4 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 5.638205e-4 |
GO:0060993 | kidney morphogenesis | 5.691414e-4 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | 5.818567e-4 |
GO:0006508 | proteolysis | 5.836762e-4 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 5.879872e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 5.918400e-4 |
GO:0006659 | phosphatidylserine biosynthetic process | 5.927551e-4 |
GO:0002521 | leukocyte differentiation | 6.064035e-4 |
GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 6.065688e-4 |
GO:0006928 | cellular component movement | 6.099178e-4 |
GO:0090185 | negative regulation of kidney development | 6.118767e-4 |
GO:0060242 | contact inhibition | 6.118767e-4 |
GO:0043066 | negative regulation of apoptosis | 6.186869e-4 |
GO:0051094 | positive regulation of developmental process | 6.226482e-4 |
GO:0045333 | cellular respiration | 6.251594e-4 |
GO:0043201 | response to leucine | 6.280501e-4 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 6.299928e-4 |
GO:0010350 | cellular response to magnesium starvation | 6.393186e-4 |
GO:0072234 | metanephric nephron tubule development | 6.434808e-4 |
GO:0016572 | histone phosphorylation | 6.507770e-4 |
GO:0010157 | response to chlorate | 6.558210e-4 |
GO:0045964 | positive regulation of dopamine metabolic process | 6.558210e-4 |
GO:0046632 | alpha-beta T cell differentiation | 6.686420e-4 |
GO:0021510 | spinal cord development | 6.782078e-4 |
GO:0044027 | hypermethylation of CpG island | 6.827751e-4 |
GO:2000543 | positive regulation of gastrulation | 7.070890e-4 |
GO:0072170 | metanephric tubule development | 7.098633e-4 |
GO:0031399 | regulation of protein modification process | 7.234057e-4 |
GO:0060562 | epithelial tube morphogenesis | 7.276214e-4 |
GO:0009743 | response to carbohydrate stimulus | 7.367581e-4 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7.372406e-4 |
GO:0048870 | cell motility | 7.524240e-4 |
GO:0001838 | embryonic epithelial tube formation | 7.821015e-4 |
GO:0043113 | receptor clustering | 7.871766e-4 |
GO:0003309 | type B pancreatic cell differentiation | 7.880894e-4 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 8.163871e-4 |
GO:0016331 | morphogenesis of embryonic epithelium | 8.183478e-4 |
GO:0046631 | alpha-beta T cell activation | 8.319777e-4 |
GO:0009617 | response to bacterium | 8.558914e-4 |
GO:0035162 | embryonic hemopoiesis | 8.572849e-4 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 8.700726e-4 |
GO:0034764 | positive regulation of transmembrane transport | 8.722408e-4 |
GO:0033238 | regulation of cellular amine metabolic process | 8.757551e-4 |
GO:0009749 | response to glucose stimulus | 8.796634e-4 |
GO:0061035 | regulation of cartilage development | 8.848656e-4 |
GO:0010941 | regulation of cell death | 8.944379e-4 |
GO:0040034 | regulation of development, heterochronic | 9.085317e-4 |
GO:0021953 | central nervous system neuron differentiation | 9.094797e-4 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 9.139054e-4 |
GO:0090196 | regulation of chemokine secretion | 9.139054e-4 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 9.366968e-4 |
GO:0072207 | metanephric epithelium development | 9.465537e-4 |
GO:0048523 | negative regulation of cellular process | 9.483327e-4 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 9.489522e-4 |
GO:0051150 | regulation of smooth muscle cell differentiation | 9.645945e-4 |
GO:0032314 | regulation of Rac GTPase activity | 9.648692e-4 |
GO:0022407 | regulation of cell-cell adhesion | 9.873597e-4 |
GO:0043931 | ossification involved in bone maturation | 9.876058e-4 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 9.876058e-4 |
GO:0072088 | nephron epithelium morphogenesis | 9.925674e-4 |
GO:0048793 | pronephros development | 9.943426e-4 |
GO:0042063 | gliogenesis | 9.996593e-4 |
GO:0071422 | succinate transmembrane transport | 1.014669e-3 |
GO:0070349 | positive regulation of brown fat cell proliferation | 1.014669e-3 |
GO:0002642 | positive regulation of immunoglobulin biosynthetic process | 1.014669e-3 |
GO:0016139 | glycoside catabolic process | 1.014669e-3 |
GO:0033627 | cell adhesion mediated by integrin | 1.022953e-3 |
GO:0090197 | positive regulation of chemokine secretion | 1.030169e-3 |
GO:0048539 | bone marrow development | 1.030169e-3 |
GO:0071479 | cellular response to ionizing radiation | 1.036776e-3 |
GO:0016570 | histone modification | 1.046908e-3 |
GO:0009134 | nucleoside diphosphate catabolic process | 1.054717e-3 |
GO:0046826 | negative regulation of protein export from nucleus | 1.058576e-3 |
GO:0070625 | zymogen granule exocytosis | 1.086423e-3 |
GO:0021954 | central nervous system neuron development | 1.095904e-3 |
GO:0042769 | DNA damage response, detection of DNA damage | 1.107797e-3 |
GO:0032331 | negative regulation of chondrocyte differentiation | 1.107797e-3 |
GO:0048754 | branching morphogenesis of a tube | 1.120368e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.127578e-3 |
GO:0072218 | metanephric ascending thin limb development | 1.129569e-3 |
GO:0072233 | metanephric thick ascending limb development | 1.129569e-3 |
GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1.129569e-3 |
GO:0051254 | positive regulation of RNA metabolic process | 1.135900e-3 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 1.137336e-3 |
GO:0032026 | response to magnesium ion | 1.149524e-3 |
GO:0009954 | proximal/distal pattern formation | 1.153660e-3 |
GO:2000179 | positive regulation of neural precursor cell proliferation | 1.170239e-3 |
GO:0042742 | defense response to bacterium | 1.172079e-3 |
GO:0030521 | androgen receptor signaling pathway | 1.179970e-3 |
GO:0061053 | somite development | 1.203634e-3 |
GO:0060675 | ureteric bud morphogenesis | 1.210779e-3 |
GO:0060065 | uterus development | 1.213168e-3 |
GO:2000833 | positive regulation of steroid hormone secretion | 1.217158e-3 |
GO:0002309 | T cell proliferation involved in immune response | 1.217158e-3 |
GO:0018026 | peptidyl-lysine monomethylation | 1.223116e-3 |
GO:0048645 | organ formation | 1.238204e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 1.245346e-3 |
GO:0055015 | ventricular cardiac muscle cell development | 1.251700e-3 |
GO:0009410 | response to xenobiotic stimulus | 1.253058e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1.274237e-3 |
GO:0001938 | positive regulation of endothelial cell proliferation | 1.279703e-3 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 1.286305e-3 |
GO:0043067 | regulation of programmed cell death | 1.286999e-3 |
GO:0048546 | digestive tract morphogenesis | 1.291619e-3 |
GO:0060525 | prostate glandular acinus development | 1.292397e-3 |
GO:0072177 | mesonephric duct development | 1.302323e-3 |
GO:0031016 | pancreas development | 1.303802e-3 |
GO:0060004 | reflex | 1.314706e-3 |
GO:0042129 | regulation of T cell proliferation | 1.322317e-3 |
GO:0060736 | prostate gland growth | 1.327711e-3 |
GO:0007218 | neuropeptide signaling pathway | 1.337447e-3 |
GO:0030325 | adrenal gland development | 1.346659e-3 |
GO:0002696 | positive regulation of leukocyte activation | 1.351618e-3 |
GO:0009887 | organ morphogenesis | 1.370474e-3 |
GO:0010470 | regulation of gastrulation | 1.370729e-3 |
GO:0034755 | iron ion transmembrane transport | 1.375213e-3 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 1.376241e-3 |
GO:0048619 | embryonic hindgut morphogenesis | 1.387272e-3 |